4Sekine I,Shao G G,Fahey M et al. What causes p53 mutations in patients with lung cancer[J].Oncol Rep,1998,5(5):1 125-1 128.
5Murakami I,Hiyama K,Ishioka S, et al. p53 gene mutations are associated with shortened survival in patients with advanced non-small cell lung cancer: an analysis of medically managed patients[J]. Clin Cancer Res,2000,6(2):526-530.
6Westra W H,Slebos R J,Offerhaus G J,et al. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung[J]. Cancer,1993,72(2):432-438.
7Huang C L,Taki T,Adachi M,et al. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer[J]. Int J Oncol,1998,12(3):553-563.
7Kishimoto J,Murakami Y,Shiraishi M,et al. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinoma of the lung[J].Cancer Res,1992,52(9):4799～4804.
8Peifer GP.p53 mutational spectra and the role of methylated CpG sequences[J].Mutat Res,2000,450(1):155～166.
9Mitsudomi T,Oyama T,Kusano T,et al.Mutation of the p53 gene as a predictor of poor prognosis in patients with non-small cell lung cancer[J].J Natl Cancer Inst,1993,85(4):2018～2023.
10Rollins LA,Leona-Kabler S,O'Sullivan MG,et al.Role of tumor suppressor genes in transplacental lung carcinogensis[J].Mol-Carcinog,1998,21(3):177～184.
